Browsing by Author Fattorusso, C

Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)Third Mission
2004Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptorLloyd, Dg; Hughes, Rb; Zisterer, Dm; Williams, Dc; Fattorusso, C; Catalanotti, B; Campiani, Giuseppe ; Meegan, M. J.Not applicable
2005Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors.Campiani, Giuseppe ; Fattorusso, C; Butini, Stefania ; Gaeta, A; Agnusdei, M; Gemma, Sandra ; Persico, M; Catalanotti, B; Savini, Luisa; Nacci, Vito; Novellino, E; Holloway, Hw; Greig, Nh; Belinskaya, T; Fedorko, Jm; Saxena, A.Not applicable
2010Discovery of Bishomo(hetero)arylpiperazines as Novel Multifunctional Ligands Targeting Dopamine D-3 and Serotonin 5-HT1A and 5-HT2A ReceptorsButini, Stefania ; Campiani, Giuseppe ; Franceschini, Silvia; Trotta, Francesco; Kumar, V; Guarino, Egeria; Borrelli, Giuseppe; Fiorini, Isabella; Novellino, E; Fattorusso, C; Persico, M; Orteca, N; SANDAGER NIELSEN, K; Jacobsen, Ta; Madsen, K; SCHEEL KRUGER, J; Gemma, Sandra Not applicable
2008Old and new targets for innovative antimalarial compounds: the different strategies of the Italian Malaria NetworkBasilico, N; Bosisio, E; Buelli, F; Campiani, Giuseppe ; Casagrande, M; Castelli, F; Coghi, P; Corbett, Y; Cortelezzi, L; D'Alessandro, S; Dell'Agli, M; Esposito, F; Fattorusso, C; Fattorusso, E; Finaurini, S; Galli, Gv; Gemma, Sandra ; Habluetzel, A; Lucantoni, L; Melato, S; Monti, D; Olliaro, P; OMODEO SALÈ, F; Parapini, S; Persico, M; Rizzi, M; Romeo, S; Rossi, F; Rusconi, C; Sparatore, A; Scafati, Ot; VAN DEN BOGAART, E; Taramelli, D; Vaiana, N; Yerbanga, S.Not applicable
2009Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77.Ferlini, C; Cicchillitti, L.; Raspaglio, G.; Bartollino, S.; Cimitan, S.; Bertucci, C.; Mozzetti, S.; Gallo, D.; Persico, M; Fattorusso, C; Campiani, Giuseppe ; Scambia, GNot applicable
2004Pyrrolo[1,3]benzothiazepine-Based Serotonin and Dopamine Receptor Antagonists. Molecular Modeling, Further Structure-Activity Relationship Studies, and Identification of Novel Atypical Antipsychotic Agents.Campiani, Giuseppe ; Butini, Stefania ; Fattorusso, C; Catalanotti, B; Gemma, Sandra ; Nacci, Vito; Morelli, E; Cagnotto, A; Mereghetti, I; Mennini, T; Carli, M; Minetti, P; DI CESARE M., A; Mastroianni, D; Scafetta, N; Galletti, B; STASI M., A; Castorina, M; Pacifici, L; Vertechy, M; SERIO S., D; Ghirardi, O; Tinti, O; Carminati, P.Not applicable
2005The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistance.Ferlini, C; Raspaglio, G; Mozzetti, S; Cicchillitti, L; Filippetti, F; Gallo, D; Fattorusso, C; Campiani, Giuseppe ; Scambia, G.Not applicable
2005Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity.Fattorusso, C; Gemma, Sandra ; Butini, Stefania ; Huleatt, P; Catalanotti, B; Persico, M; DE ANGELIS, M; Fiorini, Isabella; Nacci, Vito; Ramunno, A; Rodriquez, M; Greco, G; Novellino, E; Bergamini, A; Marini, S; Coletta, M; Maga, G; Spadari, S; Campiani, Giuseppe Not applicable
2003Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.Savini, Luisa; Gaeta, A; Fattorusso, C; Catalanotti, B; Campiani, Giuseppe ; Chiasserini, Luisa ; Pellerano, Cesare; Novellino, E; Mckissic, D; Saxena, A.Not applicable
2005Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2.Frandsen, A; Pickering, Ds; Vestergaard, B; Kasper, C; Nielsen, Bb; Greenwood, Jr; Campiani, Giuseppe ; Fattorusso, C; Gajhede, M; Schousboe, A; Kastrup, J. S.Not applicable